Preparation, characterization and cytotoxicity evaluation of tanshinone IIA nanoemulsions

Journal of Biomedical Nanotechnology

Volumn 7, Issue 4, 2011, Pages 558-567

  Chang, Li Ching ^a   Wu, Chi Lien ^b   Liu, Ching Wen ^b   Chuo, Wen Ho ^c   Li, Ping Chia ^a   Tsai, Tong Rong ^b  

^a I SHOU UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c TAJEN UNIVERSITY   (Taiwan)

Author keywords

Bladder cancer; High pressure homogenization; Nanoemulsion; Tanshinone IIA

Indexed keywords

ACTIVE COMPONENTS; BLADDER CANCERS; DISSOLUTION RATES; DOSE-DEPENDENT MANNER; ENTRAPMENT EFFICIENCY; FACTORIAL DESIGN; FAST DISSOLUTIONS; HIGH PRESSURE HOMOGENIZATION; HUMAN BLADDER CANCER; IN-VITRO; INDEPENDENT VARIABLES; MEAN PARTICLE SIZE; NANO-EMULSIONS; NANOEMULSION; OPTIMAL FORMULATION; OPTIMAL METHODS; POLYDISPERSITY INDICES; SALVIA MILTIORRHIZA BUNGE; TANSHINONE II A; TRADITIONAL CHINESE MEDICINE; TWEEN 80;

CYTOTOXICITY; OPTIMIZATION; PHOSPHOLIPIDS; POLYDISPERSITY;

HOMOGENIZATION METHOD;

PHOSPHATIDYLCHOLINE; POLYSORBATE 80; TANSHINONE IIA; ABIETANE DERIVATIVE; EXCIPIENT; HERBACEOUS AGENT; NANOPARTICLE; SURFACTANT; TANSHINONE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG SYNTHESIS; FACTORIAL DESIGN; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID SOLUBILITY; NANOEMULSION; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY; WATER CONTENT; ZETA POTENTIAL; BLADDER TUMOR; CELL CYCLE; CELL SURVIVAL; DRUG EFFECT; DRUG STABILITY; EMULSION; ISOLATION AND PURIFICATION; NANOTECHNOLOGY; PATHOLOGY; SOLUBILITY; TUMOR CELL LINE; ULTRASTRUCTURE;

CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DITERPENES, ABIETANE; DRUG STABILITY; DRUGS, CHINESE HERBAL; EMULSIONS; EXCIPIENTS; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; SOLUBILITY; SURFACE-ACTIVE AGENTS; URINARY BLADDER NEOPLASMS;

EID: 80052870295     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2011.1315     Document Type: Article

References (34)

1. B. L. Zhao, W. Jiang, Y. Zhao, J. W. Hou, and W. J. Xin, Scavenging effects of salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury. Biochem. Mol. Biol. Int. 38, 1171 (1996).
2. J. D. Adams, R. Wang, J. Yang, and E. J. Lien, Preclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditions. Chin. Med. 1, 3 (2006).
3. E. H. Cao, X. Q. Liu, J. J. Wang, and N. F. Xu, Effect of natural antioxidant tanshinone II-A on DNA damage by lipid peroxidation in liver cells. Free Radic. Biol. Med. 20, 801 (1996).
4. X. Wang, Y. Wei, S. Yuan, G. Liu, Y. Lu, J. Zhang, and W. Wang, Potential anticancer activity of tanshinone IIA against human breast cancer. Int. J. Cancer 116, 799 (2005).
5. Y. Song, S. L. Yuan, Y. M. Yang, X. J. Wang, and G. Q. Huang, Alteration of activities of telomerase in tanshinone IIA inducing apoptosis of the leukemia cells. Zhongguo Zhong Yao Za Zhi 30, 207 (2005).
6. H. Hao, G. Wang, N. Cui, J. Li, L. Xie, and Z. Ding, Pharmacokinetics, absorption and tissue distribution of tanshinone IIA solid dispersion. Planta Med. 72, 1311 (2006).
7. A. Azeem, M. Rizwan, F. J. Ahmad, Z. Iqbal, R. K. Khar, M. Aqil, and S. Talegaonkar, Nanoemulsion components screening and selection: A technical note. AAPS PharmSciTech. 10, 69 (2009).
8. T. J. Wooster, M. Golding, and P. Sanguansri, Impact of oil type on nanoemulsion formation and Ostwald ripening stability. Langmuir 24, 12758 (2008).
9. R. H. Müller and K. Peters, Nanosuspensions for the formulation of poorly soluble drugs. Preparation by a size-reduction technique. Int. J. Pharm. 160, 229 (1998).
10. V. J. Mohanraj and Y. Chen, Nanoparticles - A Review. Trop. J. Pharm. Res. 5, 561 (2006).
11. J. Vandervoort and A. Ludwig, Biocompatible stabilizers in the preparation of PLGA nanoparticles: A factorial design study. Int. J. Pharm. 238, 77 (2002).
12. D. D. Verma, S. Verma, G. Blume, and A. Fahr, Particle size of liposomes influences dermal delivery of substances into skin. Int. J. Pharm. 258, 141 (2003).
13. C. Fonseca, S. Simoes, and R. Gaspar, Paclitaxel-loaded PLGA nanoparticles: Preparation, physicochemical characterization and in vitro anti-tumoral activity. J. Control Release 83, 273 (2002).
14. D. Zhang, T. Tan, L. Gao, W. Zhao, and P. Wang, Preparation of azithromycin nanosuspensions by high pressure homogenization and its physicochemical characteristics studies. Drug Dev. Ind. Pharm. 33, 569 (2007).
15. Z. R. Su, Z. Q. Liu, and H. Zhou, Change of chemical composition of tanshinonetanshinone in concentration and drying technology (1) - degradation mechanism of Tanshinone IIA under the heat and moisture. Chin. Trad. Patent Med. 19, 5 (1997).
16. F. Yuexian, L. Junfen, and D. Chuan, Preparation and study on the inclusion complexes of two tanshinone compounds with beta-cyclodextrin. Spectrochim. Acta. A Mol. Biomol. Spectrosc. 61, 135 (2005).
17. D. K. Sarker, Engineering of nanoemulsions for drug delivery. Curr. Drug Deliv. 2, 297 (2005).
18. N. Jain, S. Akhter, G. K. Jain, Z. I. Khan, R. K. Khar, and F. J. Ahmad, Antiepileptic intranasal amiloride loaded mucoadhesive nanoemulsion: Development and safety assessment. J. Biomed. Nanotechnol. 7, 142 (2011).
19. J. Fu, D. Wang, T. Wang, W. Yang, Y. Deng, H. Wang, S. Jin, and N. He, High entrapment efficiency of chitosan/polylactic acid/tripolyphotspate nanosized microcapsules for rapamycin by an emulsion-evaporation approach. J. Biomed. Nanotechnol. 6, 725 (2010).
20. N. Bernardy, A. P. Romio, E. I. Barcelos, C. D. Pizzol, C. L. Dora, E. Lemos-Senna, P. H. H. Araujo, and C. Sayer, Nanoencapsulation of quercetin via miniemulsion polymerization. J. Biomed. Nanotechnol. 6, 181 (2010).
21. P. Boonme, V. B. Junyaprasert, N. Suksawad, and S. Songkro, Microemulsions and nanoemulsions: Novel vehicles for whitening cosmeceuticals. J. Biomed. Nanotechnol. 5, 373 (2009).
22. K. A. Shah, M. D. Joshi, and V. B. Patravale, Biocompatible microemulsions for fabrication of glyceryl monostearate solid lipid nanoparticles (SLN) of tretinoin. J. Biomed. Nanotechnol. 5, 396 (2009).
23. R. Jain and V. B. Patravale, Development and evaluation of nitrendipine nanoemulsion for intranasal delivery. J. Biomed. Nanotechnol. 5, 62 (2009).
24. C. W. Pouton, Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur. J. Pharm. Sci. 11, 93 (2000).
25. Z. Liang, S. J. Mao, Z. N. Yin, H. Jin, H. Li, and T. Chu, Preparation and quality evaluation of intravenous tanshinone II (A) emulsion. Zhongguo Zhong Yao Za Zhi 33, 1249 (2008).
26. K. Vivek, H. Reddy, and R. S. R. Murthy, Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS PharmSciTech. 8, 16 (2007).
27. R. H. Muller and C. M. Keck, Challenges and solutions for the delivery of biotech drugs-A review of drug nanocrystal technology and lipid nanoparticles. J. Biotechnol. 113, 151 (2004).
28. L. Lindfors, P. Skantze, U. Skantze, M. Rasmusson, A. Zackrisson, and U. Olsson, Amorphous drug nanosuspensions. Inhibition of Ostwald ripening. Langmuir 22, 906 (2006).
29. J. Liu, J. Zhu, Z. Du, and B. Qin, Preparation and pharmacokinetic evaluation of Tanshinone IIA solid lipid nanoparticles. Drug Dev. Ind. Pharm. 31, 551 (2005).
30. M. Grassi, D. Voinovich, E. Franceschinis, B. Perissutti, and J. Filipovic-Grcic, Theoretical and experimental study on theophylline release from stearic acid cylindrical delivery systems. Control Release 923, 275 (2003).
31. B. H. L. Bohm and R. H. Müller, Lab-scale production unit design for nanosuspensions of sparingly soluble cytotoxic drugs. Pharm. Sci. Technol. Today 28, 336 (1999).
32. L. J. Yang, C. J. Jeng, H. N. Kung, C. C. Chang, A. G. Wang, G. Y. Chau, M. J. Don, and Y. P. Chau, Tanshinone IIA isolated from Salvia miltiorrhiza elicits the cell death of human endothelial cells. J. Biomed. Sci. 12, 347 (2005).
33. X. Li, J. R. Du, B. Bai, Y. Yu, X. Y. Zheng, F. Yang, and H. Zheng, Inhibitory effects and mechanism of tanshinone IIA on proliferation of rat aortic smooth muscle cells. Zhongguo Zhong Yao Za Zhi 33, 2146 (2008).
34. L. Zhou, W. K. Chan, N. Xu, K. Xiao, H. Luo, K. Q. Luo, and D. C. Chang, Tanshinone IIA, an isolated compound from Salvia miltiorrhiza Bunge, induces apoptosis in HeLa cells through mitotic arrest. Life Sci. 83, 394 (2008).